Rowe Lab
@RoweLab_aus
Followers
148
Following
18
Media
8
Statuses
40
Molecular imaging lab investigating biomarkers (PET & blood) for neurodegenerative diseases, focusing on early detection & therapeutic intervention in AD.
Melbourne, Australia
Joined August 2022
Exciting news! Our findings on the Lumipulse #pTau217 assay were featured in @theheraldsun and @dailytelegraph. In this interview, Prof. Christopher Rowe explains the difference this blood test could make for #Alzheimers diagnosis. Have a read here:
Pleased to present our paper @eBioMedicine, on the Lumipulse plasma pTau217 assay. Lumipulse-G platform → large global installation base in clinical pathology services → better access/uptake of plasma #ptau217 into clinical practice. Link: #Alzheimers.
0
1
8
We at Rowe Lab are very proud that our PET expert, @vincentDore2 was awarded the prestigious de Leon Prize, as senior author of “CenTauR: Toward a universal scale and masks for standardizing tau imaging studies”. Time to celebrate this great achievement! #AAIC24 #AIC
2
2
22
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
471
658
4K
RT @vincentDore2: Don't miss out on the opportunity to join our team! The final day (21st) to apply for this postdoc position is fast appro….
0
5
0
RT @vincentDore2: 🌊🏄♀️ Exciting news! A postdoctoral opportunity is now available in my team in Melbourne! Join us and contribute to cutti….
jobs.csiro.au
CSIRO Postdoctoral Fellowship in PET Neuroimaging for Alzheimer's Disease
0
8
0
Trials are currently in progress for #Alzheimer's blood tests in Australia. Tune in to our interview on @7NewsMelbourne to stay informed and contribute to the journey against Alzheimer's. #Alzheimers #Research #Dementia #DementiaAwareness.
#ICYMI . Professor Chris Rowe, Clinical Lead in the Florey's Dementia Mission, spoke to @7NewsMelbourne about the efficacy of a potential new blood test that can detect early signs of Alzheimer's. In collaboration with @Austin_Health @ADNeT_Australia.& @UniMelb
0
3
12
RT @AzadehFeizpour: Exciting results!🧠✨Our latest study showcases that plasma P217+tau can distinguish Intermediate or Advanced stage #Alzh….
medrxiv.org
Background Plasma phospho-tau biomarkers, such as p217+tau, excel at identifying Alzheimer’s Disease (AD) neuropathology. However, questions remain regarding their capacity to inform AD biological...
0
2
0
🔥 Hot off the press: our new article on VMAT2 PET as a sensitive tool to detect and quantify Parkinson’s disease (PD) progression over two years.🧠 .This is a breakthrough discovery with implications for PD diagnostics and clinical trials. #Neuroscience #Parkinsons.
🔥 Hot off the press: Utilizing 18F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease .#neurology #parkinsons #biomarker #PET #NeuroTwitter
0
4
10
Key findings:.-Basal forebrain atrophy is associated with Aβ and cognitive impairment. -Ch4p is more vulnerable to AD pathology than other subregions. -The cholinergic system may be a potential target for AD early intervention.
0
1
1
Check out the paper by our collaborator, @YingXia87, on changes in basal forebrain in normal aging and Alzheimer’s disease.
🧠 How does the basal forebrain change in normal aging and Alzheimer’s disease? 🧠. Check out our new paper that reveals the patterns of volume loss in the cholinergic system over 14 years in 516 old adults from AIBL. #ENDALZ #Alzheimers .
1
1
2
We’re in dire need of a standardised scale for quantification of tau PET. Drop by the poster by @vincentDore2 at site 361 to know more about the CenTauR scale. #AAIC2023
0
6
11
Come check out the poster by @AzadehFeizpour at site 252 to know more about plasma p217+tau and how it compares to amyloid and tau PET. #AAIC2023.
How do blood biomarkers compare to amyloid and tau PET in predicting cognitive decline? Drop by poster 252 at #AAIC2023 to know more. The full paper can be found here: .
0
1
3
Enjoying day #2 of the #AAIC2023 in Amsterdam with @RoweNeuroSci , @vincentDore2 , @Nat_Krishnadas , @AzadehFeizpour and Marj, but would like to acknowledge the many of our hard-working team members back in Melbourne that are missing from this photo.
0
3
28
Excited for Day 2 of #ADRF2023 don’t miss the presentation on prognostic utility of plasma p217+tau vs amyloid and tau PET -oral discovery session at 11.20 @AzadehFeizpour @ADRF2023
0
2
7
Our latest research findings show that #Veterans are not at higher risk of developing #Alzheimers disease.
Is Service-Related Traumatic Brain Injury in #Veterans a Prelude to Alzheimer’s Disease? Read the new study now: #TBI #Alzheimers #Veterans.
1
0
0
RT @vincentDore2: Universal sampling masks for tau imaging (CenTauR) are now available for download on #GAAIN:
0
5
0
RT @ADNeT_Australia: Amyloid PET brain imaging is a valuable diagnostic tool for detecting early signs of dementia, Alzheimer's disease and….
0
5
0
Privileged to have had the Victorian minister for health, infrastructure and medical research, @MaryAnneThomas visit @TheFlorey to hear about all the exciting projects, including our brain PET dementia research #dementia #Alzheimer.
Melbourne is home to world's best brain research at @TheFlorey, with researchers working on treatments for Alzheimer's, the neurology of mental health, drugs for MND, & stem cells to cure Parkinson's. Big thanks to Prof Trevor Kilpatrick & the team for welcoming me today .
0
2
3
RT @bucklr01: Are you looking for a postdoc position in an awesome lab? Come join us! Buckley lab is seeking a postdoc (summer start, negot….
0
79
0
Check out our recent paper comparing the tau PET tracers 18F-MK6240 and flortaucipir published in @jpreventionalz1, a study led by Dr Bourgeat from .@CSIRO .#Alzheimer.
0
1
4